Preoperative intraperitoneal chemotherapy in adjuvant hyperthermia adjunctive therapy in advanced gastric cancer with high-risk of peritoneal recurrence - a multicentre randomized trial.

Status

Completed

Phases

Phase 2Phase 3

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-516042-18-00

Acronym

GastricCHIMERAtrial

Enrollment

182

Registered

2024-09-06

Start date

2021-09-08

Completion date

2025-01-28

Last updated

2024-09-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Carcinoma

Brief summary

Peritoneal recurrence rate, Recurrence rates, Quality of life assessment by means of QLQ-C30 and STO22 questionaries

Detailed description

Overall survival, Disease free survival, Ocena parametrów jakości życia przy użyciu kwestionariusza QLQC30 oraz STO22

Interventions

DRUGIRINOTECAN

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
Peritoneal recurrence rate, Recurrence rates, Quality of life assessment by means of QLQ-C30 and STO22 questionaries	—

Secondary

Measure	Time frame
Overall survival, Disease free survival, Ocena parametrów jakości życia przy użyciu kwestionariusza QLQC30 oraz STO22	—

Countries

Poland

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026